VenoStent

company

About

VenoStent is biomaterials company developing bioresorbable, smart polymers to transform vascular surgery.

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.29M
Industries
Advanced Materials,Biotechnology,Health Care,Life Science,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
VenoStent, Inc.

VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$6.18M
VenoStent has raised a total of $6.18M in funding over 2 rounds. Their latest funding was raised on Feb 23, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 23, 2021 Seed $3M 8 Creative Ventures Detail
Aug 25, 2020 Seed $150K 1 Y Combinator Detail
Jul 10, 2020 Grant $500K 1 Detail
Apr 26, 2020 Seed $535K 2 Detail
Oct 2, 2019 Non-Equity Assistant 1 MassChallenge Detail

Investors

Number of Lead Investors
Number of Investors
5
12
VenoStent is funded by 12 investors. Creative Ventures and Y Combinator are the most recent investors.
Investor Name Lead Investor Funding Round
Creative Ventures Yes Seed
Y Combinator Yes Seed
MassChallenge Yes Non-Equity Assistant
National Science Foundation Yes Grant
C3 Ventures Seed
Cowtown Angels Seed
IAG Capital Partners Seed
Kube VC Seed
Olima Ventures Seed
SP Investment Fund Seed

Employee Profiles

Number of Employee Profiles
2
VenoStent has 2 current employee profiles, including Executive Geoffrey Lucks
Executive
Executive